ArticleScience advances2025

Intratumoral mycobiome heterogeneity influences the tumor microenvironment and immunotherapy outcomes in renal cell carcinoma.

Weiming Mou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.